With regard to our hypothesis, the reduction in circulating estrogen levels caused by endocrine therapy may decrease the inhibition of AMHRII expression on the surface of breast cancer cells by estrogen; thus, more AMH can bind to its receptor and induce tumor cell apoptosis. The gene discussed is AMH; the disease is breast carcinoma.